Mimedx (MDXG) Capital Expenditures Growth (3y) (2014 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -0.66% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | -14.20% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 12.42% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 9.94% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 10.89% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 11.78% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 6.38% |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | 12.81% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 9.52% |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn | 25.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.99% |
| Mar 31, 2026 | -3.43% |
| Dec 31, 2025 | -24.68% |
| Sep 30, 2025 | -18.06% |
| Jun 30, 2025 | -22.19% |
| Mar 31, 2025 | 47.28% |
| Dec 31, 2024 | -6.81% |
| Sep 30, 2024 | -32.13% |
| Jun 30, 2024 | -36.24% |
| Mar 31, 2024 | -16.16% |
| Dec 31, 2023 | -41.70% |
| Sep 30, 2023 | -1.24% |
| Jun 30, 2023 | -9.99% |
| Mar 31, 2023 | -14.45% |
| Dec 31, 2022 | -1.46% |
| Sep 30, 2022 | 30.79% |
| Jun 30, 2022 | 14.83% |
| Mar 31, 2022 | -43.32% |
| Dec 31, 2021 | -43.78% |
| Sep 30, 2021 | -35.61% |